Applying CAR T-cell therapy to treat solid tumors is especially challenging due to the immunosuppressive tumor microenvironment (TME). While our modular RevCAR system enhances the safety and ...
β 2-microglobulin (β2m), the light chain of MHC-I, is required for MHC-I stability and cell-surface expression in tumor cells. 8,9 Increasing evidence has demonstrated that genetic deficiency of B2M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results